Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients with leukemia or lymphoma

Journal of Clinical Oncology

Volumn 19, Issue 3, 2001, Pages 697-704

  Pui, C H ^a   Mahmoud, H H ^a   Wiley, J M ^a   Woods, G M ^a   Leverger, G ^a   Camitta, B ^a   Hastings, C ^a   Blaney, S M ^a   Relling, M V ^a   Reaman, G H ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLANTOIN; CREATININE; DRUG ANTIBODY; DRUG METABOLITE; PHOSPHORUS; POTASSIUM; RASBURICASE; RECOMBINANT URATE OXIDASE; SR 29142; UNCLASSIFIED DRUG; URATE OXIDASE; URIC ACID;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIALYSIS; DISEASE CONTROL; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; DRUG EXCRETION; DRUG HALF LIFE; DRUG INDUCED DISEASE; DRUG MECHANISM; DRUG METABOLISM; DRUG SAFETY; FEMALE; HUMAN; HYPERURICEMIA; INFANT; LEUKEMIA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; PHOSPHATE BLOOD LEVEL; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; PROPHYLAXIS; URIC ACID BLOOD LEVEL; URINARY EXCRETION;

EID: 0035253501     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2001.19.3.697     Document Type: Article

References (25)

1. Uric acid excretion and renal function in the acute hyperuricemia of leukemia: Pathogenesis and therapy or uric acid nephropathy
2. Prevention and management of acute hyperuricemia in childhood leukemia
3. Hyperuricemia in neoplastic disease in children: Prevention with allopurinol, a xanthine oxidase inhibitor
4. Tumor lysis syndrome: Pathogenesis and management
5. Acute tumor lysis syndrome: A review of 37 patients with Burkitt's lymphoma
6. Renal dysfunction and hyperuricemia at presentation and relapse of acute lymphoblastic leukemia
7. Use of allopurinol for prevention and control of hyperuricemia in patients with neoplastic disease
8. Purine excretion during tumor lysis in children with acute lymphocytic leukemia receiving allopurinol: Relationship to acute renal failure
9. The effectiveness of the xanthine oxidase inhibitor allopurinol in the treatment of gout
10. Urinary xanthine stones: A rare complication of allopurinol therapy
11. Xanthine nephropathy in a patient with lymphosarcoma treated with allopurinol
12. Nephropathy, xanthinuria, and orotic aciduria complicating Burkitt's lymphoma treated with chemotherapy and allopurinol
13. Acute renal failure complicating Burkitt's lymphoma treated with chemotherapy and allopurinol
14. Enzymatic uricolysis: A study of the effect of a fungal urate-oxydase
15. Molecular evolution of the urate oxidase-encoding gene in hominoid primates: Nonsense mutations
16. Urate-oxidase prophylaxis of uric acid-induced renal damage in childhood leukemia
17. Urate oxidase in prevention and treatment of hyperuricemia associated with lymphoid malignancies
18. Advances in the management of malignancy-associated hyperuricemia
19. Blood chemistries/body fluids
20. Quantitative determination of an extremely polar compound allantoin in human urine by LC-MS/MS based on the separation on a polymeric amino column
21. Development of a two-site immunoassay of recombinant urate oxidase (SR 29142) and its use for determination of pharmacokinetic parameters in rats and baboons
22. Renal and metabolic complications of undifferentiated and lymphoblastic lymphomas
23. Acute renal failure at onset of therapy for advanced stage Burkitt lymphoma and B cell acute lymphoblastic lymphoma
24. Improved survival for children with B-cell acute lymphoblastic leukemia and stage IV small noncleaved-cell lymphoma: A Pediatric Oncology Group study
25. Acute lymphoblastic leukemia